These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 8429100)
1. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. Kubota R; Fujiyoshi T; Izumo S; Yashiki S; Maruyama I; Osame M; Sonoda S J Neuroimmunol; 1993 Feb; 42(2):147-54. PubMed ID: 8429100 [TBL] [Abstract][Full Text] [Related]
2. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy. Mita S; Sugimoto M; Nakamura M; Murakami T; Tokunaga M; Uyama E; Araki S Am J Trop Med Hyg; 1993 Feb; 48(2):170-7. PubMed ID: 8447519 [TBL] [Abstract][Full Text] [Related]
3. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP. Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429 [TBL] [Abstract][Full Text] [Related]
4. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. Kubota R; Umehara F; Izumo S; Ijichi S; Matsumuro K; Yashiki S; Fujiyoshi T; Sonoda S; Osame M J Neuroimmunol; 1994 Aug; 53(1):23-9. PubMed ID: 7914211 [TBL] [Abstract][Full Text] [Related]
5. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Montanheiro PA; Oliveira AC; Posada-Vergara MP; Milagres AC; Tauil C; Marchiori PE; Duarte AJ; Casseb J Braz J Med Biol Res; 2005 Nov; 38(11):1643-7. PubMed ID: 16258633 [TBL] [Abstract][Full Text] [Related]
6. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis. Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696 [TBL] [Abstract][Full Text] [Related]
7. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients. Ramirez E; Cartier L; Torres M; Barria M J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906 [TBL] [Abstract][Full Text] [Related]
8. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. Adaui V; Verdonck K; Best I; González E; Tipismana M; Arévalo J; Vanham G; Campos M; Zimic M; Gotuzzo E J Neurovirol; 2006 Dec; 12(6):456-65. PubMed ID: 17162661 [TBL] [Abstract][Full Text] [Related]
9. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Kira J; Koyanagi Y; Yamada T; Itoyama Y; Goto I; Yamamoto N; Sasaki H; Sakaki Y Ann Neurol; 1991 Feb; 29(2):194-201. PubMed ID: 2012389 [TBL] [Abstract][Full Text] [Related]
10. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers. Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912 [TBL] [Abstract][Full Text] [Related]
12. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Yamano Y; Nagai M; Brennan M; Mora CA; Soldan SS; Tomaru U; Takenouchi N; Izumo S; Osame M; Jacobson S Blood; 2002 Jan; 99(1):88-94. PubMed ID: 11756157 [TBL] [Abstract][Full Text] [Related]
13. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. Nagai M; Usuku K; Matsumoto W; Kodama D; Takenouchi N; Moritoyo T; Hashiguchi S; Ichinose M; Bangham CR; Izumo S; Osame M J Neurovirol; 1998 Dec; 4(6):586-93. PubMed ID: 10065900 [TBL] [Abstract][Full Text] [Related]
14. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment. Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Takenouchi N; Yamano Y; Usuku K; Osame M; Izumo S J Neurovirol; 2003 Feb; 9(1):29-35. PubMed ID: 12587066 [TBL] [Abstract][Full Text] [Related]
16. Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy. Kira J; Koyanagi Y; Yamada T; Itoyama Y; Tateishi J; Akizuki S; Kishikawa M; Baba E; Nakamura M; Suzuki J Ann Neurol; 1994 Aug; 36(2):149-56. PubMed ID: 8053650 [TBL] [Abstract][Full Text] [Related]
17. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression. Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218 [TBL] [Abstract][Full Text] [Related]
18. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. Hara H; Morita M; Iwaki T; Hatae T; Itoyama Y; Kitamoto T; Akizuki S; Goto I; Watanabe T J Exp Med; 1994 Sep; 180(3):831-9. PubMed ID: 8064235 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I. Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP. Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]